CLINICAL_TRIALS
withdrawal
· 2022-08-23
Clinical Trial Update: Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery [Phase 4]
Summary
Phase 4 trial investigating topical hemostatic powder with hydrophilic polymer and potassium ferrate for nail surgery was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Nail Diseases | Phase 4 | Status: WITHDRAWN